Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Gastroenterology and Hepatology Clinical Trials Facility

The Gastroenterology Unit and Hepatology Clinical Trials Facility hosts a team of internationally recognised consultants specialising in inflammatory bowel and hepatobiliary conditions. The facility has excellent links with global decision makers in pharmaceutical companies at both clinical and scientific levels. ​

The clinical trials facility sits alongside the Gastroenterology and Hepatology daycase unit located on ward 6b of the John Radcliffe hospital.​

The facility hosts a large portfolio of work covering both commercial and academic clinical trials. The service is also integrated with colorectal, upper gastrointestinal, hepatobiliary and transplant surgical units, with involvement in novel surgical therapies including bariatric surgery and small intestinal transplantation.​
Clinical trial visits are carried out by our large team of experienced and knowledgeable research nurses and clinical research practitioners.​

In-house innovation leads to the development of novel therapeutics, devices, and techniques providing a stream for early phase trials and opportunities for patients to take part in trials that could change the face of future treatment.

 

 

 

 

 

 

 

 

 

 

Our team

In this section

The Bio-medical Research Council (BRC), a part of the Oxford Hospital Radcliffe Trust (OHRT), funds research and many of our staff are involved in BRC research.

Our research is funded from a variety of funders. Their support allows our research to focus on the basic and clinical research domains to accelerate knowledge translation from the bedside to the bench, and back again.